在代谢性疾病中向离子稳态:分子机制和向疗法
Yanjiao Zhang1, Kaile Ma1, Xinyi Fang2
1Institute of Metabolic Diseases, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.
Pharmacological research
|January 5, 2025
概括
保持适当的离子平衡是预防糖尿病和高血压等代谢疾病的关键. 向离子稳态为这些日益增长的健康问题提供了一个有希望的新疗法策略.
科学领域:
- 生物医学科学 生物医学科学
- 代谢疾病研究研究
- 离子运输生理学 离子运输生理学
背景情况:
- 代谢性疾病 (高血压,糖尿病,肥胖,MASLD,动脉样硬化) 在全球范围内正在上升.
- 破坏的离子平衡与代谢疾病的发展有关.
- 在代谢性疾病中离子稳态的精确机制在很大程度上是未知的.
研究的目的:
- 审查离子稳态在代谢性疾病病原发生中的作用.
- 评估离子稳态作为潜在的治疗目标.
- 探索针对离子通道和载体的当前和未来的药理学策略.
主要方法:
- 在代谢疾病中对离子恒温机制的文献综述.
- 对针对离子通道和输送器的药理干预措施的分析.
- 讨论新兴的治疗方法,包括基因和个性化治疗.
主要成果:
- 离子稳态破坏是代谢疾病进展的重要因素.
- 离子通道和输送器代表了可行的治疗点.
- 现有和新型药物显示出通过调节离子平衡来管理代谢疾病的潜力.
结论:
- 向离子稳态为代谢性疾病提供了一种新的治疗途径.
- 未来的策略可能包括基因疗法和针对离子通道调节的个性化药物.
- 恢复离子平衡为治疗代谢障碍提供了新的视角.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Targets for Drug Action: Overview
6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K
Electron Transport Chain: Complex I and II
11.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
11.1K
Regulated Protein Degradation
2.5K
2.5K
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
Non-gated Ion Channels
6.7K
Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
6.7K


